Evidence map›Paper›PMID 40970624›Full record

ArticleACS applied bio materials2025

Bovine Serum Albumin-Trypsin Sponges for Enhanced Enzymatic Stability and Protein Digestion Efficiency.

Maria Kaeek, Luai R Khoury

Abstract read
In one paragraph

Article in ACS applied bio materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Maria KaeekTechnion Israel Institute of Technology, Department of Materials Science and Engineering, Haifa 32000, Israel.
Luai R KhouryTechnion Israel Institute of Technology, Department of Materials Science and Engineering, Haifa 32000, Israel.ORCID 0000-0002-9581-4917

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein-based materials are emerging as versatile platforms for biocatalysis and biomedical applications due to their structural tunability and intrinsic catalytic capabilities. Here, we present a light-activated strategy for the scalable fabrication of enzymatically active sponges via covalent cross-linking of trypsin within a bovine serum albumin (BSA) matrix. This method leverages photoinitiated Tyr-Tyr coupling, creating a nanoscale enzyme distribution that addresses critical limitations observed in conventional enzyme immobilization methods─namely, instability, autolysis, and restricted reusability. By modulating trypsin concentration and acetic acid (AA) during synthesis, we achieve precise control over cross-link density, enhancing both mechanical flexibility and catalytic accessibility. The sponges retain over 50% of their enzymatic activity after 30 days of storage and maintain ∼60% functionality across ten reuse cycles. Structural integrity and enzyme distribution were validated by attenuated total reflection-Fourier transform infrared (ATR-FTIR) and fluorescence resonance energy transfer (FRET) microscopy, revealing preserved secondary structure and uniform spatial embedding. Proteolytic performance was benchmarked against Cytochrome c, Concanavalin A, and Fetal Bovine Serum, demonstrating enhanced cleavage efficiency and substrate accessibility. This light-activated, reusable platform introduces a scalable approach for stable enzyme immobilization with broad implications for proteomics, biocatalysis, therapeutic devices, and advanced biomedical diagnostics.

Indexed as

Biocompatible MaterialsSerum Albumin, BovineTrypsinAnimalsCattleEnzyme StabilityMaterials TestingParticle SizeProteolysisSurface PropertiesBiocompatible MaterialsSerum Albumin, BovineTrypsinBiocatalytic SpongesEngineered Protein ScaffoldsEnzyme ImmobilizationNanoscale FRET ImagingProteolytic Biocatalysis

Identifiers

PMID40970624
PMCPMC12541704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.